ClinicalTrials.gg
CompletedNCT06755957Updated Oct 8, 2026

Effectiveness of Standard Exercises and Wall Angels Exercise in Young Adults With Kyphotic Posture

An interventional study of EXERCISE TRAINING WITH OR WITHOUT MEDICATION and CONTROL in Kyphosis Thoracic and Exercise Therapy, sponsored by Suleyman Demirel University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Suleyman Demirel University · Not applicable, Interventional, and Treatment

Updated Oct 8, 2026Now CompletedStart date moved+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

Kyphosis-oriented exercise programs consist of isolated stretching, strengthening, and breathing exercises. However, the literature emphasizes that the body is a kinetic chain in many musculoskeletal disorders and supports holistic exercise approaches. To our knowledge, the effects of a complex exercise such as the Wall Angels exercise have not been studied in the kyphotic population. The aim of our study is to investigate whether the Wall Angels exercise combined with standard kyphosis exercises performed at home has additional effects and to contribute to the optimization of kyphosis rehabilitation programs.

Read the detailed description

The study was planned as a randomized controlled double-blind study and will consist of two groups: intervention (Wall angels exercise combined with kyphosis and breathing exercises) and control (Only kyphosis and breathing exercises). The G-Power version-3.1.9 power analysis measurement method was used to determine the sample size. According to the Power Analysis conducted by taking into account the results of the studies of Elpeze and Usgu (15), it was calculated that at least 38 volunteers would be included in the study for a p\<0.05 with an effect size of 0.5 and a power of 85%. The outcome measures of the study will be demographic characteristics, pain (Visual Analog Scale), trunk flexibility assessment, thoracic range of motion assessment, kyphosis index, scapula protraction, upper extremity function, respiratory capacity, postural habit and postural awareness level, and quality of life assessment. Statistical analyses will be performed using SPSS version 23.0 (IBM SPSS Statistics; IBM Corporation, Armonk, NY, USA) software. Descriptive statistics of the data will be given using mean and standard deviation for numerical variables; and percentages for qualitative variables. The Kolmogorov-Smirnov test will be used to examine the conformity of the data to normal distribution as a result of descriptive analyses. Intra-group comparisons will be evaluated using the Dependent Groups T test for groups with normal distribution, and the Wilcoxon signed ranks test for those not with normal distribution. In order to compare pre-post training values between groups, the Independent Groups T test for data with normal distribution, and the Mann Whitney-U test for data not with normal distribution will be used. The level of statistical significance will be accepted as p\<0.05.

02

Conditions studied

  • Kyphosis Thoracic
  • Exercise Therapy

Browse trials for

Keywords

  • Corrective Exercise
  • Kyphosis
  • Posture
  • Thoracic Mobility
03

In context

Kyphosis

132 studies on the registry are indexed under Kyphosis; 31 are open to participants now.

This study's enrollment of 44 is close to the median of 44 across 82 interventional studies indexed under Kyphosis.

Browse Kyphosis studies →

Lead sponsor

Suleyman Demirel University is the lead sponsor of 127 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Volunteering to participate in the study and giving written consent
  2. Being a woman/man between the ages of 18-25
  3. Having a kyphotic posture

Exclusion criteria

Exclusion Criteria:

  1. Having a musculoskeletal disorder (scoliosis, etc.)
  2. Having a neurological system disorder
  3. Having a cardiopulmonary system disorder
  4. Having a fracture or surgery related to the spine, rib cage, or upper extremity within the last year
  5. Participating in an exercise program for kyphosis within the last 6 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Intervention arm

    1\. Posture Exercises (3 sets \* 15 reps): 1a) Shoulder lift 1b) Shoulder forward circles 1c) Shoulder backward circles 2. Pectoral Stretch Exercise (3 sets \* 10 reps; each stretch held for 30 seconds; for right and left sides) 3. Back Strengthening Exercise (3 sets \* 15 reps) 4. Self Mobilization Exercise (3 sets \* 10 reps; for right and left sides) 5. Cat-Camel Exercise (3 sets \* 10 reps) 6. Breathing Exercises (3 sets \* 10 reps): 6a) Diaphragmatic breathing 6b) Segmental breathing 7. Wall angels exercise (2 sets \* 10 reps)

    Other: EXERCISE TRAINING WITH OR WITHOUT MEDICATION

  • Active comparator
    Control arm

    1\. Posture Exercises (3 sets \* 15 reps): 1a) Shoulder lift 1b) Shoulder forward circles 1c) Shoulder backward circles 2. Pectoral Stretch Exercise (3 sets \* 10 reps; each stretch held for 30 seconds; for right and left sides) 3. Back Strengthening Exercise (3 sets \* 15 reps) 4. Self Mobilization Exercise (3 sets \* 10 reps; for right and left sides) 5. Cat-Camel Exercise (3 sets \* 10 reps) 6. Breathing Exercises (3 sets \* 10 reps): 6a) Diaphragmatic breathing 6b) Segmental breathing

    Other: CONTROL

Interventions

  • OtherEXERCISE TRAINING WITH OR WITHOUT MEDICATION

    Posture exercise, stretching exercise, breathing exercise, back strengthening exercise, self-mobilization exercise, cat camel exercise and postural correction exercise will be applied.

  • OtherCONTROL

    Posture exercise, stretching exercise, breathing exercise, back strengthening exercise, self-mobilization exercise, cat camel exercise will be applied.

06

What researchers measure

Primary outcomes

  1. Postural Habits and Awareness Scale

    Postural habits and awareness levels will be assessed with the Postural Habits and Awareness Scale (PHAS). PHAS is a valid and reliable tool developed to assess postural habits and awareness in healthy adults. This scale consists of four sub-dimensions: postural habits and awareness, awareness of factors that impair posture, ergonomic awareness and positional awareness. PHAS is structured as a 5-point Likert scale consisting of 19 items, 7 of which are related to postural habits and 12 to postural awareness. Participants rate each item on a scale ranging from 1 (strongly disagree) to 5 (strongly agree). The total score on the scale ranges from 0 to 95, with higher scores indicating better postural habits and awareness.

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. Visual Analog Scale (VAS)

    The level of pain will be assessed by the participant using the Visual Analog Scale (VAS) (0: no pain; 100: unbearable pain).

    Time frame: From enrollment to the end of treatment at 6 weeks

  3. Trunk Hyperextension and Lateral Flexion Flexibility Measurement

    Trunk flexibility will be measured using trunk hyperextension and lateral flexion (for right and left sides) tests and a tape measure. For the trunk hyperextension measurement, the participant is asked to stand facing the wall and with their pelvis touching the wall. First, the distance between the sternum notch and the wall is measured and recorded in this position. Then, the participant's pelvis is supported and they are asked to move their trunk backwards away from the wall. At the last point, the sternum notch and wall distance is measured again. The difference between the first and last measurements is recorded in centimeters. For the trunk lateral flexion measurement, the participant stands with their back to the wall. The tape measure is placed distal to the 3rd phalanx. The measure is recorded in centimeters. The measurement is repeated for the other side.

    Time frame: From enrollment to the end of treatment at 6 weeks

  4. Flexruler Measurement (kyphosis index)

    The kyphosis index will be calculated using the appropriate formula after the measurement with the flexible ruler. The flexible ruler is a metal covered with plastic, approximately 60 cm long, which can be molded according to the contour of the spine to measure the curves in the sagittal plane. To determine the kyphosis index, the spinous processes of the C7 and T12 vertebrae are determined as references and the participant's kyphosis shape is evaluated with the flexible ruler and transferred to paper. The kyphosis index is calculated by evaluating the angle formed between the distance between C7 and T12, defined as thoracic length, and the distance of the kyphosis peak, defined as thoracic width, to the thoracic length line.

    Time frame: From enrollment to the end of treatment at 6 weeks

  5. Inclinometer Tests

    Thoracic range of motion will be measured using an inclinometer for flexion and rotation (for the right and left sides). The spinous processes of the T1 and T12 vertebrae are marked as reference points. For the measurement of thoracic flexion, the inclinometer is placed vertically on the T1 vertebra and the participant is asked to lean forward so that the lumbar region does not participate in the movement. The value obtained at this point is recorded in degrees for the T1 vertebra flexion. Immediately afterwards, the inclinometer is placed vertically on the T12 vertebra and the T12 vertebra flexion is recorded in degrees. For thoracic right and left rotations, the inclinometer is placed horizontally on the T1 vertebra. The participant is asked to rotate the thoracic region and the value at the last point is recorded in degrees for the T1 vertebra. Immediately afterwards, the degree for the T12 vertebra is recorded.

    Time frame: From enrollment to the end of treatment at 6 weeks

  6. Scapula Protraction Test

    For the right and left scapula, the inferior edge of the scapula is determined and the vertical distance to the midline of the spine is measured with a tape measure and recorded in centimeters.

    Time frame: From enrollment to the end of treatment at 6 weeks

  7. Chest Circumference Measurement

    Respiratory capacity will be recorded in centimeters by taking the difference between the chest circumference measurements obtained at maximum inspiration and maximum expiration from the axillary, epigastric and subcostal regions. The greater the difference, the better the pulmonary function.

    Time frame: From enrollment to the end of treatment at 6 weeks

  8. the Quick Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire

    The DASH is a questionnaire designed to assess disability resulting from upper extremity injuries, activity limitations, leisure activities, and work participation restrictions. The questionnaire consists of three sections. The first section contains 30 items: 21 items assessing difficulties in activities of daily living, 5 items assessing symptoms, and 4 items assessing social function, work, sleep, and self-esteem. This first section determines the Function/Symptom Model (DASH-FS) score. All questions are scored on a 5-point Likert-type scale (1: no difficulty, 5: cannot do at all) (0: no disability, 100: maximum disability). Scores range from 0 to 100 for each section (0: no disability, 100: maximum disability).

    Time frame: From enrollment to the end of treatment at 6 weeks

  9. SRS22 Patient Outcome Questionnaires

    Quality of life will be assessed with the Scoliosis Research Society Patient Questionnaire. The SRS-22 is a valid and reliable scoliosis-specific quality of life scale developed by Haher et al. and modified by the Scoliosis Research Society to assess the current perception of medical status and self-image in patients with idiopathic scoliosis. The scale consists of five subscales consisting of 22 questions, including pain, general body image, spine function, mental health, and treatment satisfaction. Participants rate each question on a scale of 1 (most negative) to 5 (most positive). Scores for each subscale range from 0 to 25, while the total score for treatment satisfaction ranges from 0 to 10. Higher scores on the scale indicate improved quality of life, while lower scores reflect decreased quality of life.

    Time frame: From enrollment to the end of treatment at 6 weeks

07

Study locations

1 site
  • Suleyman Demirel University Faculty of Health Science
    Isparta, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2024 to primary completion in Mar 2025, 2 months.

Of 56 non-industry interventional studies with no phase under Kyphosis, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 30. This study's 2 months is below that.

Counting every sponsor, half of 58 studies reached it within 9 months; a quarter within 4 and three quarters within 30.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 8, 2026: start Oct 2024 → Dec 2024, primary completion Oct 2024 → Mar 2025 and completion Jan 2025 → Mar 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 13, 2024
First posted
Jan 1, 2025
StartActual
Dec 25, 2024was Oct 2024
Primary completionActual
Mar 10, 2025was Oct 2024
CompletionActual
Mar 10, 2025was Jan 2025
Last update
Oct 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Oct 8, 2026
Start date
Oct 1, 2024→Dec 25, 2024
Oct 8, 2026
Primary completion
Oct 3, 2024→Mar 10, 2025
Oct 8, 2026
Study completion
Jan 20, 2025→Mar 10, 2025 (actual)
Oct 8, 2026
Enrollment
40 (estimated)→44 (actual)
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    Enrolling by invitation→Completed
    Start date Oct 1, 2024→Dec 25, 2024
    Primary completion Oct 3, 2024→Mar 10, 2025
    Study completion Jan 20, 2025→Mar 10, 2025 (now actual)
    Enrollment 40 (estimated)→44 (actual)
    + 3 other changes: arm descriptions, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06755957
Responsible party
Mesut ERGAN (Assistant Professor, Suleyman Demirel University) — Principal investigator
First posted
Jan 1, 2025
Start date
Dec 25, 2024
Primary completion
Mar 10, 2025
Completion
Mar 10, 2025
Last update
Oct 8, 2026

Study contacts

Mesut Ergan, asst. prof.
study director · Suleyman Demirel University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion